2026 Q1 Portfolio Activity
In 2026 Q1, NEXTBio Capital Management LP maintained a portfolio of 24 distinct positions. The most significant new addition was SUMMIT THERAPEUTICS INC, now representing 0.79% of the total fund value. They heavily accumulated shares in COMPASS PATHWAYS PLC, increasing the position by 168.6%. The fund also reduced its exposure to COMPASS THERAPEUTICS INC by 23.9%.
Position History
hover any row below to update
Loading…
Total Positions
24
Quarter
2026 Q1
Top Holding
TERN (14.8%)
Top 10 Concentration
71.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-24 of 24
NEXTBio Capital Management LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERN
TERNS PHARMACEU...
|
Healthcare | 14.80% | 13.06% |
#1
Prev: #1
|
8.0 |
—
|
53,344 | 9.7% |
P
S
|
604,534 | $31,871,032 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 11.24% | 11.76% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
229,619 | $24,201,843 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 9.40% | 6.74% |
#3
2
Prev: #5
|
5.8 |
—
|
no change | no change |
P
S
|
3,149,907 | $20,253,902 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 8.28% | 7.67% |
#4
1
Prev: #3
|
4.8 |
—
|
no change | no change |
P
S
|
999,967 | $17,839,411 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 5.19% | 3.05% |
#5
8
Prev: #13
|
5.6 |
—
|
1,268,776 | 168.6% |
P
S
|
2,021,407 | $11,178,381 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 5.09% | 4.24% |
#6
3
Prev: #9
|
5.0 |
—
|
58,492 | 86.5% |
P
S
|
126,078 | $10,965,004 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 4.95% | 4.83% |
#7
1
Prev: #8
|
2.5 |
—
|
-479 | -0.3% |
P
S
|
183,225 | $10,654,534 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 4.79% | 5.08% |
#8
1
Prev: #7
|
2.9 |
—
|
no change | no change |
P
S
|
82,686 | $10,306,810 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 3.87% | 6.86% |
#9
5
Prev: #4
|
4.0 |
—
|
104,753 | 32.5% |
P
S
|
426,736 | $8,342,689 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 3.44% | 3.54% |
#10
1
Prev: #11
|
1.9 |
—
|
34,783 | 2.7% |
P
S
|
1,333,484 | $7,400,836 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 3.22% | 5.92% |
#11
5
Prev: #6
|
1.8 |
—
|
-530 | -0.0% |
P
S
|
1,306,800 | $6,926,040 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 3.18% | 2.59% |
#12
3
Prev: #15
|
2.3 |
—
|
no change | no change |
P
S
|
372,856 | $6,849,365 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 3.08% | 2.95% |
#13
1
Prev: #14
|
1.7 |
—
|
-92,101 | -15.0% |
P
S
|
523,619 | $6,634,253 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 2.98% | 3.85% |
#14
4
Prev: #10
|
3.7 |
—
|
38,796 | 41.1% |
P
S
|
133,239 | $6,422,120 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.57% | 2.58% |
#15
1
Prev: #16
|
1.5 |
—
|
-262 | -0.3% |
P
S
|
95,223 | $5,533,409 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.34% | 2.00% |
#16
2
Prev: #18
|
3.4 |
—
|
35,369 | 36.9% |
P
S
|
131,188 | $5,049,426 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 2.08% | 3.51% |
#17
5
Prev: #12
|
0.8 |
—
|
-265,801 | -23.9% |
P
S
|
848,204 | $4,486,999 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 1.96% | 2.29% |
#18
1
Prev: #17
|
1.3 |
—
|
-44,223 | -19.4% |
P
S
|
184,063 | $4,231,608 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 1.85% | 1.75% |
#19
1
Prev: #20
|
1.2 |
—
|
-158 | -0.1% |
P
S
|
149,592 | $3,977,651 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 1.60% | 1.69% |
#20
1
Prev: #21
|
2.6 |
—
|
20,000 | 12.2% |
P
S
|
183,362 | $3,449,039 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.56% | 1.99% |
#21
2
Prev: #19
|
3.1 |
—
|
9,877 | 23.1% |
P
S
|
52,655 | $3,366,761 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 1.23% | 1.25% |
#22
Prev: #22
|
1.5 |
—
|
no change | no change |
P
S
|
131,796 | $2,653,053 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 0.79% | — |
#23
Prev: #—
|
3.8 |
—
|
89,717 | — |
NEW
|
89,717 | $1,701,034 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ACET
ADICET BIO INC
|
Healthcare | 0.50% | 0.78% |
#24
1
Prev: #23
|
1.2 |
—
|
no change | no change |
P
S
|
157,827 | $1,074,802 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-24 of 24 holdings